(Q30011093)

22 May 2017

Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia (English)

1 reference

22 May 2017

0 references

prostatic hypertrophy

1 reference

1

Hunter Wessells

1 reference

22 May 2017

12

Jacob Rajfer

1 reference

22 May 2017

Johnny Roy

2

1 reference

22 May 2017

John Bannow

3

1 reference

22 May 2017

John Grayhack

4

1 reference

22 May 2017

Alvin M Matsumoto

5

1 reference

22 May 2017

Lisa Tenover

6

1 reference

22 May 2017

Richard Herlihy

7

1 reference

22 May 2017

William Fitch

8

1 reference

22 May 2017

Richard Labasky

9

1 reference

22 May 2017

Stephen Auerbach

10

1 reference

22 May 2017

Raul Parra

11

1 reference

22 May 2017

Jennifer Culbertson

13

1 reference

22 May 2017

Michael Lee

14

1 reference

22 May 2017

Mark A Bach

15

1 reference

22 May 2017

Joanne Waldstreicher

16

1 reference

22 May 2017

PLESS Study Group

17

1 reference

22 May 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

22 May 2017

1 reference

22 May 2017

61

1 reference

22 May 2017

3

1 reference

22 May 2017

579-584

1 reference

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

22 May 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

The relationship between sexual life and urinary condition in the French community

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

Sexual dysfunction in men with lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

Symptom status and quality of life following prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902401-9

7 January 2021

10.1016/S0090-4295(02)02401-9

Identifiers

DOI

1 reference

22 May 2017

1 reference